During the past decade, PMG Research of Raleigh, LLC conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 30 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PMG Research of Raleigh, LLC" #1 sponsor was "Pfizer" with 16 trials, followed by "Allergan" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Esperion Therapeutics, Inc." with 2 trials sponsored and "Philip Morris Products S.A." with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PMG Research of Raleigh, LLC" #1 collaborator was "The Cleveland Clinic" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "PMG Research of Raleigh, LLC" are "Dyslipidemia" (3 trials), "Migraine" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Episodic Migraine" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "PMG Research of Raleigh, LLC" in a lesser frequency.

Most popular intervention types in "PMG Research of Raleigh, LLC" are "Drug" (30 trials), "Biological" (13 trials), "Other" (5 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Rimegepant" (3 trials), "Atogepant" (2 trials), "CC" (2 trials) and "PRC-4016" (2 trials). Other intervention names were less common.

The vast majority of trials in "PMG Research of Raleigh, LLC" are 48 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "PMG Research of Raleigh, LLC". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in PMG Research of Raleigh, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PMG Research of Raleigh, LLC, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".